For people with advanced cancer, clinical trials can offer access to promising treatments before they’re widely available. A remarkable case from The Christie, a specialist cancer center in Manchester, England, shows what’s possible when the right patient is matched with the right treatment, and why personalized medicine is becoming so important.
A difficult diagnosis
A 51-year-old welder from Greater Manchester was diagnosed in 2020 with intrahepatic cholangiocarcinoma, a rare and aggressive cancer of the bile ducts inside the liver. Before his diagnosis, his main symptom was severe shoulder pain that kept him awake at night. By the time the cancer was found, it had spread to his liver and adrenal gland, and the tumors were too large to remove with surgery. It was classed as stage 4, and doctors estimated he had about a year to live.
Joining a clinical trial
He was referred to an immunotherapy trial at The Christie. Immunotherapy works by helping the body’s immune system recognize and attack cancer cells. The drug being tested was already approved for other cancers, including some lung, kidney and esophageal cancers, and was being studied in bile duct cancer. Its name wasn’t released because the trial was ongoing.
The results
- The tumors shrank dramatically. The liver tumor went from about 12 cm to 2.6 cm, and the adrenal tumor from about 7 cm to 4.1 cm.
- Surgery became possible. The smaller tumors could now be removed.
- No active cancer remained. When the removed tissue was examined, it contained only dead cancer cells. Tests were repeated because the result was so striking.
- He stayed cancer-free. Follow-up scans continued to show no cancer, without further treatment.
Why it worked so well for him
His oncologist, Professor Juan Valle, explained that the patient’s cancer cells carried a high number of genetic mutations. Tumors with many mutations tend to look more “foreign” to the immune system, making them more likely to respond to immunotherapy. Most people with this type of cancer don’t have as many mutations, so the treatment won’t work as dramatically for everyone. That’s why testing tumors for specific genetic features is becoming a key part of cancer care.
What this means for people facing cancer
- Ask about tumor testing. Genetic or biomarker testing of a tumor can show whether targeted therapies or immunotherapy might help.
- Ask about clinical trials. Trials can offer access to new treatments and close monitoring. Your oncologist or a major cancer center can help you find options.
- Seek specialist care for rare cancers. Cancers like bile duct cancer benefit from teams with specific expertise.
- Get support. Patient organizations, counselors and support groups can help with the emotional and practical challenges of cancer.
Know the warning signs
Bile duct cancer is often found late because early symptoms can be vague. Possible signs include yellowing of the skin or eyes (jaundice), itchy skin, pale stools, dark urine, abdominal pain, unexplained weight loss and fatigue. Pain can sometimes be felt in unexpected places, such as the shoulder. These symptoms usually have other causes, but persistent or unexplained symptoms deserve a medical check.
Keep perspective
This is one person’s story, and individual results vary widely. Not every patient will respond the same way, and trials don’t always succeed. But cases like this help researchers understand who benefits most from new treatments.
The bottom line
A man given about a year to live with advanced bile duct cancer became cancer-free after an immunotherapy trial, likely because his tumor had many mutations. His story highlights the growing power of personalized cancer treatment and the value of clinical trials.
This article is for general information and isn’t medical advice. Talk with your healthcare provider about your individual needs.
